| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | WT-161 |
|---|
| Description | WT-161 is a potent, selective, and bioavailable HDAC6 (histone deacetylase-6) inhibitor (IC50 0.40 nM). It is selective for HDAC6 over HDAC3 (IC50 = 51.61 nM) and induces α-tubulin acetylation, an HDAC6-dependent process, with minimal effect on global lysine acetylation. WT161 inhibits growth of patient-derived multiple myeloma cell lines with IC50 values ranging from 1.5 to 4.7 μM. WT161 enhances the cytotoxicity of bortezomib (Cat. No. 1846) and carfilzomib (Cat. No. 2385) against patient-derived multiple myeloma cells. MW: 458.56. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (E)-8-(2-(4-(Diphenylamino)benzylidene)hydrazinyl)-N-hydroxy-8-oxooctanamide |
|---|
| Gene, Accession, CAS # | CAS: 1206731-57-8 |
|---|
| Catalog # | B2219-25 |
|---|
| Price | |
|---|
| Order / More Info | WT-161 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|